The Valley Desk

NCT05207865 · Interventional trial

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Overall registry status Completed

Phase 4

Conditions Episodic Migraine, Migraine, Phonophobia, Photophobia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov